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Objective: Pain is the main reason patients report Osteoarthritis (OA), yet current analgesics remain
relatively ineffective. This study investigated both peripheral and central mechanisms that lead to the
development of OA associated chronic pain.
Design: The monoiodoacetate (MIA) model of OA was investigated at early (2e6 days post injection) and
late (>14 days post injection) time points. Pain-like behaviour and knee histology were assessed to
understand the extent of pain due to cartilage degradation. Electrophysiological single-unit recordings
were taken from spinal wide dynamic range (WDR) neurons to investigate Diffuse Noxious Inhibitory
Controls (DNIC) as a marker of potential changes in descending controls. Immunohistochemistry was
performed on dorsal root ganglion (DRG) neurons to assess any MIA induced neuronal damage.
Furthermore, qPCR was used to measure levels of glia cells and cytokines in the dorsal horn.
Results: Both MIA groups develop pain-like behaviour but only late phase (LP) animals display extensive
cartilage degradation. Early phase animals have a normally functioning DNIC system but there is a loss of
DNIC in LP animals. We found no evidence for neuronal damage caused by MIA in either group, yet an
increase in IL-1b mRNA in the dorsal horn of LP animals.
Conclusion: The loss of DNIC in LP MIA animals suggests an imbalance in inhibitory and facilitatory
descending controls, and a rise in the mRNA expression of IL-1b mRNA suggest the development of
central sensitisation. Therefore, the pain associated with OA in LP animals may not be attributed to
purely peripheral mechanisms.
© 2018 Published by Elsevier Ltd on behalf of Osteoarthritis Research Society International.96
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Pain is the major symptom of OA and the reason patients report
the disease,1 yet the discordance between radiographic joint
damage observed and the associated pain renders it difﬁcult to
understand which aspects of the disease trigger pain.2 Animal
models of OA provide powerful tools to investigate mechanisms
how structural joint pathology progresses and the associated
development of chronic pain.3 An OA-like phenotype can be
induced in animals by chemically injuring the joint with mono-
iodoacetate (MIA), causing chondrocyte cell death and articular
cartilage erosion.4e6 The MIA model is particularly relevant for the.M. Lockwood, Department of
ty College London, Gower St,
3737; Fax: 144-2076797298.
. Lockwood).
lf of Osteoarthritis Research Societ
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https://doi.org/10.1016/j.joca.pain associated with OA as animals develop hyperalgesia and
allodynia in primary and secondary sites.7e9 Furthermore, the MIA
model has many advantages including the lack of invasiveness, the
simplicity of induction, the pain-like behaviour that develops, and
the histological changes that occur in the articular cartilage.10
Diffuse noxious inhibitory controls (DNIC) are a unique form of
endogenous inhibitory control of spinal wide dynamic range
(WDR) neurons, where both noxious and innocuous evoked
neuronal activity can be strongly inhibited by a second concomitant
noxious conditioning stimulus outside of the receptive ﬁeld.11e13
The activation of supraspinal structures and functional descend-
ing controls are required for DNIC to induce neuronal inhibition, as
DNIC cannot be observed in anesthetized animals with spinal cord
(SC) transection.14,15 Speciﬁcally, the conditioning noxious stimulus
activates descending inhibitory noradrenergic transmission to the
SC, and neuronal inhibition is mediated by a ﬁnal post-synaptic
mechanism.13,16 DNIC is lost in a neuropathic model, conﬁrming
that an imbalance in descending inhibitory and facilitatory controlsy International.
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YJOCA4378_proof ■ 9 January 2019 ■ 2/11are contributing to the maintenance of chronic pain.13,17e19 Simi-
larly, the human counterpart of DNIC, Conditioned Pain Modulation
(CPM), has been demonstrated to be lost in a variety of chronic pain
states.20,21 Furthermore, measuring CPM responses in patients has
been shown to predict the likelihood of patients developing chronic
pain and how responsive they will be to drugs that restore this
descending inhibition.22,23 Overall, assessing DNIC or CPM provides
a useful method for investigating the functionality of descending
controls.
Variations with monoaminergic descending pathways have
been demonstrated over the course of the MIA model, so this study
investigated DNIC in both the early inﬂammatory phase (EP) and
late chronic phases (LP) of the model.24 Furthermore, a neuropathic
component of the MIA model has previously been reported, so MIA
induced neuropathy was explored further to investigate if this was
contributing to dysregulation of descending controls.25
Methods
Animals
In all experiments, male Sprague Dawley rats were used. Food
andwater were provided ab libitum, with cages kept in a 12 h light/
dark cycle. All experiments were performed in accordance with the
UK Animals (Scientiﬁc Procedures) Act 1986.
The MIA model
Male SpragueeDawley rats (190e210 g for early phase (EP) and
120e140 g for late phase) were anaesthetized with isoﬂuorane, the
ventral surface of the hind limb was clipped of hair and the knee
area cleaned with clorhexidine. Arthritis was induced by an intra-
rticular injection of 2 mgMIA (Sigma) in 25 mL of 0.9% saline, with a
27 g needle into the left knee. Sham animals were assigned
randomly and received an intrarticular injection of 25 mL 0.9% saline
only, and assessed at the same time points as MIA animals.
Behaviour
For all behavioural testing the experimenter was blinded to
experimental or control groups. Testing was carried out on days 2,
4, 7 and 14 post injection. Animals were acclimatized to the
equipment before testing. Mechanical hypersensitivity was tested
using the up-down method as previously described (EP n ¼ 10, EP
sham (EPS) n¼ 10, late phase (LP) n¼ 10, LP sham (LPS) n¼ 10).26,27
Von Frey ﬁlaments were applied to the plantar hind paw and
withdrawal ﬂinching or shaking was counted as a positive
response. Weight bearing assessment was carried out using an
incapacitance tester (Linton Instrumentation) (EP n ¼ 15, EPS
n ¼ 12, LP n ¼ 14, LPS n ¼ 14). With one hind paw in contact with
each force platform, the force exerted by each hind paw was
measured over a 5 s period and repeated 3 times per animal. The
average weight placed on the ipsilateral limb was quantiﬁed as a
percentage of both hind paws.
Electrophysiology
Electrophysiological experiments were carried out 2e6 days
post MIA injection for EP animals (n ¼ 18) and 14e20 days post
injection for LP animals (n ¼ 35) as previously described (Urch and
Dickenson 2003). Brieﬂy, animals were anesthetized for the dura-
tion of the experiment with isoﬂuorane (1.5%) delivered in a
gaseous mix of O2 (33%) and N2O (66%). A laminectomy was per-
formed to expose the L4-L5 segments of the SC. Extracellular single
unit recordings were made from deep dorsal horn WDR neuronsPlease cite this article as: Lockwood SM et al., Characterisation of perip
Osteoarthritis, Osteoarthritis and Cartilage, https://doi.org/10.1016/j.joca.(Lamina V-VI) using parylene coated tungsten electrodes (A-M
systems). All WDR neurons used in this study responded to both
innocuous and noxious stimulations in a graded manner coding
intensity. Data was captured and analysed by a CED 1401 interface
coupled to a computer running Spike2 software (Cambridge Elec-
tronic Design; rate functions).
DNIC study design
Firstly, the pre-conditioned mechanically evoked neuronal
ﬁring rates were quantiﬁed in response to 8 g, 26 g and 60 g von
Frey ﬁlament stimulation applied to the hind paw. This was
repeated 3 times to obtain a stable pre-conditioned response
(where all neurons met the inclusion criteria of <10% variation in
action potential ﬁring). For the DNIC response, the von Frey ﬁla-
mentswere applied to the receptive ﬁeld with a concurrent noxious
ipsilateral ear pinch (15.752.3 mm Bulldog Serreﬁne, Interfocis,
Linton) or noxious ipsilateral knee pinch (0.75 cm clampwas placed
around the knee). This trial was repeated and pre-conditioned and
DNIC responses were calculated as the mean from the two trials. A
DNIC response was quantiﬁed as an inhibition on mechanically
evoked neuronal ﬁring in presence of the conditioning noxious
pinch. A 1-min nonstimulation recovery period was allowed be-
tween each test, while a 10-min nonstimulation recovery period
was allowed between each trial to ensure neuronal responses had
returned to baseline (EP n ¼ 19 neurons from 18 animals, EPS
n ¼ 13, LP n ¼ 41 neurons from 35 animals, LPS n ¼ 25).
Knee histology
Following electrophysiology, animals were terminally anaes-
thetised and knee joints were dissected and ﬁxed in 4% para-
formaldehyde (PFA) for 24e48 h. The knees were decalciﬁed in
Immunocal® (Quarttet) for approximately 1 week. The knee tissue
was then processed with a series of ethanol and wax washes, cut
into 10 mM serial sections using a microtome (Microm HM 360) and
stained with toluidine blue. Scoring was blinded and carried out by
two individuals using a system previously described (Glasson et al.,
2010) (Table I). For the maximum score the highest score
throughout the entire kneewas taken, while the average maximum
score is an average of the highest scoring condyle from each slide
(EP n ¼ 6, EPS n ¼ 6, LP n ¼ 9, LPS n ¼ 5).
Fast blue neuronal tracer
Animals were anaesthetized with ketamine (n ¼ 3) [0.6 ml
sterile saline, 0.1 ml medetomidine hydrochloride (1 mg/ml),
0.24 ml ketamine (0.3 mg/ml)], with 250 mL injected inter-
peritoneally per 100 g of rat. 25 mL of Fast Blue (2% w/v in dH2O)
(Polysciences Europe GmbH) was injected in the knee. The animals
were bought back to consciousness with the reversing agent ati-
pamezole (5 mg/ml), where 25 mL was injected subcutaneously per
100 g of animal.
Immunohistochemistry
Animals were terminally anaesthetised and transcardially
perfused with 4% PFA (EP n ¼ 3, EPS n ¼ 3, LP n ¼ 5, LPS n ¼ 4). The
ipsilateral L3-L5 dorsal root ganglion (DRG)s were dissected and
post-ﬁxed in 4% PFA overnight. Tissue was placed in 30% sucrose
overnight, mounted in OCT, frozen in liquid nitrogen and stored
at 80C. Transverse 10 mM sections were cut on a cryostat and
placed on SuperFrost Plus slides. Slides were incubated with
blocking buffer (10% donkey serum and 0.02% Triton-X-100 in PBS),
for 6 h at room temperature. Slides were incubated with primaryheral and central components of the rat monoiodoacetate model of
2018.12.017
Table I
Knee histology scores
Grade Osteoarthritic damage
0 No damage
0.5 Some loss of toluidine blue staining
1 Small superﬁcial lesions of the articular cartilage
2 Small lesions immediately below the superﬁcial layer of articular cartilage
3 Large lesions or erosion of the articular cartilage covering up to 20% of the condyle
4 Loss of articular cartilage tissue from 20% to 50% of the condyle surface
5 Loss of articular cartilage tissue from 50% to 80% of the condyle surface
6 Loss of articular cartilage tissue from more than 80% of the condyle surface
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YJOCA4378_proof ■ 9 January 2019 ■ 3/11antibodies (bIII-tubulin - Invitrogen, mouse monoclonal, 1:1000,
ATF-3 - Santa Cruz, rabbit polyclonal, 1:500) overnight at room
temperature and incubated with secondary antibodies conjugated
with Alexa-488 (anti-mouse, 1:1000) (Invitrogen), or Alexa-564
(anti-rabbit, 1:1000) (Invitrogen) for 2 h at room temperature.
Slides were mounted with Fluoromount-G and 4 DRG slices per
animal were imaged using a Zeiss Imager Z.1 microscope, and
neuronal diameter was measured using ImageJ.
qPCR
Animals were terminally anaesthetised with an overdose of
isoﬂourane and the ipsilateral lumbar dorsal horn and L3-L5 DRGs
were dissected (EP n¼ 4, EPS n¼ 4, LP n¼ 4, LPS n¼ 4), snap frozen
in liquid nitrogen and stored at 80C. RNA was extracted from
homogenized tissue using a RNAse microkit (Qiagen). First strand
cDNA synthesis was performed on 500 ng RNA using a Superscript
III Reverse Transcriptase kit (Invitrogen) according to manufac-
turers instructions with deoxynucleotide-triphosphates (Promega),
and random primers (Promega). mRNA levels of IL-1b, TNFa, IL-6,
ATF-3, Iba1, and glial ﬁbrillary acid protein (GFAP) were measured
with quantitative PCR using speciﬁc primers (Table II) and Light-
Cycler® 480 SYBR Green I master mix (Roche). The mRNA levels
were normalized to GAPDH and expressed as either 2-LCT values
or relative to sham groups.
Statistical analysis
Statistical analyses were performed using SPSS v22 (IBM,
Armonk). All data plotted represents the mean ± SEM. For behav-
iour and histological studies when comparing independent sam-
ples, a KruskalleWallis test was used to compare data from MIA
and sham animals. A relationship between behaviour and histology
was tested with linear regression analysis, were R2 represents the
strength of a linear relationship and signiﬁcance was calculated
from an F test. For electrophysiology, statistical differences in
neuronal responses with noxious conditioning ear or knee pinch
were determined using a two-way repeated-measures ANOVAwith
Bonferroni post hoc test. For Fast Blue experiments, differences
between Fast blue positive neurons in the DRGs was assessed with
a Friedmans test. For qPCR experiments, the data expressed relativeTable II
Primer sequences
Gene Forward sequence (5‘-3’)
IL-1b AGGAGAGACAAGCAACGACA
Iba1 TCCCCACCTAAGGCCACCAGC
ATF-3 GGTCGCACTGACTTCTGAGG
TNFa CGTCGTAGCAAACCACCAAGC
IL-6 TCTCTCCGCAAGAGACTTCC
GFAP CAACCTCCAGATCCGAGAA
GAPDH CTGCACCACCAACTGCTTAG
Please cite this article as: Lockwood SM et al., Characterisation of perip
Osteoarthritis, Osteoarthritis and Cartilage, https://doi.org/10.1016/j.joca.to sham was tested with a KruskalleWallis test and the data
expressed as 2-LCT values was compared to sham controls with an
independent samples t-test. Asterisks denote statistically signiﬁ-
cantly differences (*P < 0.05, **P < 0.01, ***P < 0.001).Results
Pain behaviour and cartilage degradation in MIA animals
Both EP and LP MIA animals developed mechanical hypersen-
sitivity on the ipsilateral hind paw and avoided putting weight on
the injured limb. EP MIA-injected animals demonstrated a reduc-
tion of weight placed on the MIA injected limb compared to sham
controls [Fig. 1(A)] (KruskalleWallis day 2: P ¼ 0.001, day 4:
P ¼ 0.126). LP MIA animals also demonstrated a signiﬁcant reduc-
tion in the weight placed on the injected limb compared to sham
controls at all days tested (KruskalleWallis day 2: P ¼ 0.017, day 4:
P ¼ 0.001, day 7: P ¼ 0.002, day 14: P ¼ 0.001) [Fig. 1(B)]. Both EP
and LP MIA animals demonstrated a reduced paw withdrawal
threshold on the ipsilateral hind paw compared to sham controls
(KruskalleWallis. EP day 2: P ¼ 0.003, day 4: P ¼ 0.058, LP day 2:
P ¼ 0.06, day 4: P ¼ 0.025, day 7: P ¼ 0.002, day 14: P ¼ 0.001),
indicating the development of secondary mechanical hyperalgesia
[Fig. 1(C) and (D)].
EPMIA animals displayed very little cartilage damage; therewas
no signiﬁcant difference in knee scores compared to sham controls
(KruskalleWallis, max score: P ¼ 0.304, average score: P ¼ 0.533)
[Fig. 1(E), I and (J)]. Histology in LP MIA animals showed extensive
cartilage damage [Fig. 1(F)], and knee scores were signiﬁcantly
higher than sham controls (KruskalleWallis, max score: P ¼ 0.001,
average score: P ¼ 0.006) [Fig. 1I and (J)].
The MIA model has faced criticism that while it represents the
symptoms associated with the development of OA it may not
accurately model the joint structural changes; the pain phenotype
may be attributed to the neurotoxicity of MIA destroying other
tissues surrounding the joint.3,25,28 The results from EP MIA ani-
mals agree with this concept as rats develop signiﬁcant pain-like
behaviour despite the absence of joint pathology. However, we
demonstrate a relationship between cartilage damage and the
pain-like behaviour by day 14. Interestingly, in LP MIA animals a
negative linear relationship exists between knee scores and weightReverse sequence (5‘-3’) Source
TTTGGGATCCACACTCTCCAG Invitrogen
CGTCTCCTCGGACCACTGGA Sigma
CTCTGGCCGCTCTCTGGA Sigma
ATGGCGGAGAGGAGGCTGACT Sigma
CCGGACTTGTGAAGTAGGGA Sigma
TCTTGAGGTGGCCTTCTGAC Sigma
TGATGGCATGGACTGTGG Sigma
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YJOCA4378_proof ■ 9 January 2019 ■ 5/11bearing or paw withdrawal threshold, such that animals with
higher knee histology scores place less weight and withdraw at
lower mechanical forces on the ipsilateral hind paw (Linear
regression analysis, weight bearing: R2 ¼ 0.5343, P ¼ 0.0253, PWT:
R2 ¼ 0.2812, P ¼ 0.1420) (Fig. 1(K) and L).
DNIC in MIA animals
The presence of DNIC was conﬁrmed by a reduction in me-
chanically evoked neuronal ﬁring, induced by a conditioning
noxious ear or knee pinch. In EP animals the conditioning ear and
knee pinch considerably reduced neuronal ﬁring for all mechanical
stimulations in both ipsilateral and contralateral WDR neurons
(Two way ANOVA, Ipsi: 8 g: ear: P < 0.0001, knee: P < 0.0001, 26 g:
ear: P < 0.001, knee: P < 0.0001, 60 g: ear: P < 0.0001, knee:
P < 0.0001, Contra: 8 g ear: P ¼ 0.072, uninjured knee: P ¼ 0.802,
MIA knee: P¼ 0.793, 26 g: ear: P¼ 0.004, uninjured knee: P¼ 0.171,
MIA knee: P¼ 0.214, 60 g: ear P¼ 0.038, uninjured knee: P¼ 0.196,
MIA knee: P ¼ 0.498) [Fig. 2(A), (B) and (C)]. Yet, in LP MIA animals
there was consistently no reduction in mechanically evoked
neuronal ﬁring with a conditioning noxious ear pinch, in either
ipsilateral or contralateral WDR neurons, indicating an alteration in
the endogenous inhibitory system (Two way ANOVA, Ipsi: 8 g:
P ¼ 0.184, 26 g: P ¼ 0.456, 60 g: P ¼ 1, Contra: 8 g: P ¼ 0.683, 26 g:
P¼ 0.084, 60 g: P¼ 1) (Fig. 2(D), (E), (F), (G), (H) and I). Remarkably,
a reduction in neuronal ﬁring could be induced in some LP animals
with a conditioning noxious knee pinch, indicating the DNIC sys-
tem is not completely abolished if the conditioning stimulus is high
(Two way ANOVA, Ipsi: 8 g: P ¼ 0.095, 26 g: P < 0.0001, 60 g:
P < 0.0001, Contra: 8 g: P¼ 0.866, 26 g: P¼ 0.0476, 60 g: P¼ 0.346)
(Fig. 2(D), (E), (F), (J), (K) and L).
Fast Blue neuronal tracer
Peripheral afferent ﬁbres that took up Fast Blue projected from
L2 to S1 DRGs [Fig. 3(C)]. The L4 and L5 DRGs had signiﬁcantly
higher percentages of neurons showing positive staining for Fast
Blue, with L4 DRGs having 5.7% of neurons stained (Friedmans, vL2:
P < 0.0001, vL3: P¼ 0.025, vS1: P¼ 0.001) and L5 DRGs having 3.4%
of neurons stained (Friedmans, vL2: P ¼ 0.013, vS1: P ¼ 0.40). Cu-
mulative sum analysis indicated that for L3-L6 DRGs the size dis-
tribution for Fast Blue positive neurons was very similar to the size
distribution of the total neurons within the DRG [Fig. 3(C), (D), (E)
and (F)], indicating that both small and large diameter peripheral
afferent ﬁbres innervate the knee. The contralateral DRGs did not
show positive Fast blue staining (data not shown).
ATF3 expression in MIA animals
ATF-3 is a transcription factor, which is upregulated in response
to stressful stimuli and is considered a sensitive marker for
detecting neuronal damage.28 No ATF-3 staining was observed in
L3-L5 DRGs taken from either EP (day 4) or LP (day 14) MIA animalsFig. 1. Shows the pain behaviour and knee histology in early phase (EP) and late phase (LP) M
less weight on the injured limb than sham controls (EP n ¼ 15, early phase sham (EPS) n ¼ 12
limb than sham controls at all time points tested (LP n ¼ 14, late phase sham (LPS) n ¼ 14). C
EPS n ¼ 10). D) LP MIA animals have a signiﬁcantly reduced paw withdrawal threshold than s
very little cartilage degradation. F) LP MIA animals display extensive cartilage damage. G-
histology score, LP MIA animals have a signiﬁcantly higher knee histology score than their re
to their respective sham control group (EP n ¼ 6, EPS n ¼ 6, LP n ¼ 9, LPS n ¼ 5). I) For avera
than their respective sham control group, but EP MIA animals do not have a signiﬁcantly hig
There is a signiﬁcant negative linear relationship between average knee histology score and
linear relationship between knee histology score and paw withdrawal threshold or weight
regression analysis, R2 ¼ strength of relationship and P value calculated from F-test of overal
sham.
Please cite this article as: Lockwood SM et al., Characterisation of perip
Osteoarthritis, Osteoarthritis and Cartilage, https://doi.org/10.1016/j.joca.[Fig. 4(A)].25 Furthermore, there was no signiﬁcant increase in the
mRNA expression of ATF-3 in the ipsilateral L3-L5 DRGs in EP or LP
MIA animals compared to sham controls (KruskalleWallis: EP v
Sham P ¼ 0.094, LP v Sham P ¼ 0.197, independent-samples t-test:
EP: P ¼ 0.743, LP: P ¼ 0.339) [Fig. 4(C)], suggesting MIA is not
causing substantial nerve trauma in MIA animals. Conﬁrming the
validity of the antibody, ATF-3 expression was observed in the
nucleus of lumbar DRG cells taken from rats with neuropathy
[Fig. 4(B)].
Central inﬂammatory changes in the dorsal horn
An increased number of activated microglia has previously been
reported in the ipsilateral SC of MIA animals, which is thought to
contribute to the development of central sensitisation.25,30 There-
fore, the mRNA expression of the microglia marker Ionized calcium
binding adaptor molecule 1 (Iba1) and astrocyte marker GFAP were
assessed in the dorsal horn using qPCR in MIA and sham animals.
There was weak evidence for a rise in Iba1 mRNA expression in LP
MIA animals but this effect was not signiﬁcant (EP: P ¼ 0.669, LP:
P ¼ 0.176) [Fig. 5(A) and (C)]. We observed no difference in GFAP
mRNA expression levels between MIA and sham animals (EP:
P ¼ 0.839, LP: P ¼ 0.805), indicating there is no increase in the
number of astrocytes in the dorsal horn following MIA injection at
these time points [Fig. 5(A) and (D)].
The increased release of proinﬂammatory cytokines from acti-
vated spinal glia, in particular IL-1b, TNFa, and IL6 have been
demonstrated following peripheral injury.31,32 The mRNA expres-
sion of IL-6 and TNFa in the dorsal horn remained relatively con-
stant in both MIA and sham groups (IL-6; EP: P ¼ 0.285, LP:
P¼ 0.161, TNFa; EP: P¼ 0.846, LP: P ¼ 0.439) [Fig. 5(B), (F) and (G)].
However, there was a signiﬁcant increase in the mRNA expression
of IL-1b in the ipsilateral dorsal horn of LPMIA animals compared to
sham (P ¼ 0.028), but this was not found in EP MIA animals
(P ¼ 0.699).
Discussion
We demonstrate that EP MIA animals develop signiﬁcant pain-
like behaviour despite histology indicating a lack of cartilage
degradation, which agrees with previous reports.33,34 MIA causes
an initial inﬂammatory inﬁltrate of monocytes, neutrophils and
basophils in the joint, peaking around day 3, thus pain behaviour in
EP animals may be due to the general toxicity of MIA causing an
inﬂammatory response in the joint.6,10 However, only cartilage
damage was scored with histology and since cartilage is both
anueral and avascular it cannot be the direct cause of pain.35
Therefore, the pain behaviour observed in EP MIA animals may
be a result of damage to other joint structures, such as the syno-
vium. The pain-like behaviour observed in the EP MIA model may
not be a result of joint pathology that is typical of human OA, and
representative of the mechanisms driving OA associated pain. LP
MIA animals present with structural joint damage, including loss ofIA animals. Scale bars ¼ 500 mM. A) early inﬂammatory phase (EP) MIA animals place
). B) late chronic phases (LP) MIA animals place signiﬁcantly less weight on the injured
) EP MIA animals have a reduced paw threshold compared to sham controls (EP n ¼ 10,
ham controls at all time points tested (LP n ¼ 10, LPS n ¼ 13). E) EP MIA animals display
H) EP and LP sham animals display no cartilage degradation H) For maximum knee
spective sham control group, while EP MIA animals have similar knee histology scores
ge knee histology score LP MIA animals have a signiﬁcantly higher knee histology score
her average knee score than sham controls (EP n ¼ 6, EPS n ¼ 6, LP n ¼ 9, LPS n ¼ 5). J)
the weight placed on the injured limb in LP MIA animals (n ¼ 9). There is a negative
placed on the injured limb in LP animals (n ¼ 9). (AeH: KruskalleWallis. KeL: Linear
l signiﬁcance. *P < 0.05, **P < 0.01). EP ¼ EP MIA, EPS ¼ EP sham, LP ¼ LP MIA, LPS ¼ LP
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Fig. 2. Shows the Diffuse Noxious Inhibitory Controls (DNIC) expression in EP and LP MIA animals. A) A conditioning noxious ipsilateral ear and knee pinch produced a signiﬁcant
reduction in mechanically evoked neuronal ﬁring in ipsilateral wide dynamic range (WDR) neurons in EP MIA animals (n ¼ 19 neurons from 18 animals). B) A conditioning ear pinch
and a conditioning pinch placed on both the MIA injured and uninjured knee reduced mechanically evoked neuronal ﬁring in contralateral WDR neurons (n ¼ 5). C) A representative
trace from an ipsilateral WDR neuron in an EP MIA animal, showing three baseline responses and a DNIC induced reduction in neuronal ﬁring. D) In LP MIA animals a conditioning
noxious ear pinch no longer produces a reduction in neuronal ﬁring in ipsilateral WDR neurons, but there is a signiﬁcant decrease in neuronal ﬁring with a conditioning noxious knee
pinch on the MIA injured knee (n ¼ 41 neurons from 35 animals). E) Electrophysiological recordings from contralateral WDR neurons in LP MIA animals show that a conditioning
noxious ear pinch or knee pinch placed on the uninjured knee no longer produce a reduction in neuronal ﬁring, yet a contralateral knee pinch on the MIA injured knee does produce a
reduction in neuronal ﬁring (n ¼ 7). F) A representative trace from an ipsilateral WDR neuron in a LP MIA animal, showing three baseline responses, a conditioning noxious ear pinch
no longer produces a reduction in neuronal ﬁring yet a conditioning noxious knee pinch does. G-I) The conditioned response as a percentage of the baseline in EP and LP MIA animals
and sham controls with a conditioning noxious ear pinch (G ¼ 8 g, H ¼ 26 g, I ¼ 60 g). This shows a consistent reduction in neuronal ﬁring in EP MIA and both sham groups, but no
reduction in neuronal ﬁring in LP MIA animals with noxious ear pinch. J-L) The conditioned response as a percentage of the baseline in EP and LP MIA animals and sham controls with
a conditioning noxious knee pinch (J ¼ 8 g, K ¼ 26 g, L ¼ 60 g). This shows a consistent reduction in neuronal ﬁring with a conditioning noxious knee pinch in EP and sham groups,
while the response is more varied in LP MIA animals with some animals expressing DNIC and some showing no reduction in neuronal ﬁring (EP n ¼ 19 neurons from 18 animals, EPS
n ¼ 13, LP n ¼ 41 neurons from 35 animals, LPS n ¼ 25). (AeE: Two-way ANOVA with Bonferroni correction, GeL: KruskalleWallis. *P < 0.05, **P < 0.01, ***P < 0.001).
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Fig. 3. Shows neurons in ipsilateral lumbar DRGs taking up a Fast blue neuronal tracer. Green ¼ bIII-tubulin, Blue ¼ Fast blue neuronal tracer, all scale bars ¼ 100 mM. A) T10-S1
DRGs B) There are a signiﬁcantly higher number of Fast blue positive neurons in L4 and L5 DRGs (n ¼ 3). C) The size distribution of neurons taking up the neuronal tracer is similar to
the overall size distribution, indicating both small and large neurons innervate the knee (B: Friedmans. *P < 0.05, **P < 0.01, ***P < 0.001).
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YJOCA4378_proof ■ 9 January 2019 ■ 7/11articular cartilage and in some cases exposure of subchondral bone,
which has been demonstrated to be associated with the resultant
pain behaviour.36 Indeed, a linear relationship was shown between
knee histology score and the weight placed on the ipsilateral limb.
Although this is insufﬁcient evidence to demonstrate causality, this
does agree with previous evidence that MIA-induced joint pa-
thology depends upon time, with later time points more accurately
modeling the structural joint pathology and pain that occur in
human OA.10,31Please cite this article as: Lockwood SM et al., Characterisation of perip
Osteoarthritis, Osteoarthritis and Cartilage, https://doi.org/10.1016/j.joca.We show that EPMIA animals have a normally functioning DNIC
as both concurrent noxious ear and knee pinch produced a signif-
icant reduction in mechanically evoked neuronal ﬁring. On the
other hand, there was a loss of DNIC in both ipsilateral contralateral
WDR neurons of LP MIA animals as the conditioning ear pinch no
longer produced a reduction in neuronal ﬁring, indicating a bilat-
eral loss of inhibitory control, which is similar to that observed in
SNL animals.13 A functional DNIC system relies on a balance be-
tween descending noradrenergic inhibitory pathways andheral and central components of the rat monoiodoacetate model of
2018.12.017
Fig. 4. Shows ATF-3 expression in EP and LP MIA animals. Green ¼ bIII-tubulin, Red ¼ ATF-3, all scale bars ¼ 100 mM. A) There was no positive ATF-3 staining in ipsilateral lumbar
DRGs in either MIA or sham group (EP n ¼ 3, EPS n ¼ 3, LP n ¼ 5, LPS n ¼ 4). B) There was extensive positive ATF-3 staining in ipsilateral lumbar DRGs taken from animals with
neuropathy (n ¼ 2). C) The levels of ATF-3 mRNA expression in ipsilateral lumbar DRGs are similar between MIA animals and sham controls (EP n ¼ 4, EPS n ¼ 3, LP n ¼ 4, LPS n ¼ 4)
(C: mRNA expression normalized to sham controls was tested with a KruskalleWallis, for mRNA expression expressed as 2-DCT values an independent samples t-test was used).
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YJOCA4378_proof ■ 9 January 2019 ■ 8/11facilitatory serotonergic pathways,13,19 so we suggest an imbalance
in descending controls develops in LP MIA animals.24,37 Speciﬁcally,
a reduction in descending noradrenergic inhibitory controls and an
enhanced descending serotonergic facilitatory drive acting at 5-HT3
receptors in the SC has been demonstrated in LP 2 mg MIA ani-
mals.24,37 Furthermore, while NSAIDs are effective at relieving
hyperalgesia and allodynia in EP MIA animals, they are ineffective
in LP MIA animals, which further indicates central changes.7
Overall, the pain behaviour in EP animals is likely a result of pe-
ripheral sensitisation, yet in LP animals central changes lead to an
imbalance in inhibitory and faciliatory descending controls from
the brainstem.
Remarkably, in some LP MIA animals a reduction in neuronal
ﬁring was observed when the conditioning noxious pinch was
placed on the injured knee. This indicates that the DNIC system is
not completely abolished and we propose that the imbalance in
descending controls is masking the expression of DNIC, which
agrees with previous studies demonstrating DNIC can be re-
established pharmacologically.13,19 Previous studies using electro-
physiological recordings from joint afferents have demonstrated
MIA produced a graded sensitisation and increased ﬁring rate,Please cite this article as: Lockwood SM et al., Characterisation of perip
Osteoarthritis, Osteoarthritis and Cartilage, https://doi.org/10.1016/j.joca.while a Nav1.8 channel blocker reduced the ﬁring rate of joint af-
ferents in response to noxious rotation of the joint.38,39 Thus
noxious conditioning stimulation of the MIA injured knee produces
enhanced ﬁring of joint afferents and an increased transduction of
the nocicieptive signal to the dorsal horn. Therefore, the condi-
tioning MIA injured knee pinch may now produce a sufﬁcient
nociceptive signal to activate suppressed descending inhibitory
controls and produce a small level of neuronal inhibition.
Histology studies indicated that in areas of extreme cartilage
degradation there was exposure of the subchondral bone, which
may lead to peripheral nerve damage. This study demonstrated
that the majority of knee joint afferents were localized in L4 and L5
DRGs, while a previous study found that the majority of sub-
chondral bone afferents are localized in the L3 DRGs.40 Interest-
ingly, no upregulated ATF-3mRNA expression could be identiﬁed in
ipsilateral L3-L5 DRGs in either EP or LP MIA groups, suggesting a
lack of nerve trauma in knee joint or subchondral bone afferents.
This contrasts with previous MIA studies that identiﬁed substantial
ATF-3 expression in lumbar DRGS. However, the time post MIA
injection when ATF-3 expression arises differs between studies,
with one identifying ATF-3 staining as soon as day 3, and othersheral and central components of the rat monoiodoacetate model of
2018.12.017
Fig. 5. Shows mRNA expression of glia cells and cytokines in the lumbar dorsal horn of EP and LP MIA animals (EP n ¼ 4, EPS n ¼ 4, LP n ¼ 4, LPS n ¼ 4). A) mRNA expression of Iba1
and glial ﬁbrillary acid protein (GFAP) normalized to sham. B) mRNA expression of pro-inﬂammatory cytokines normalized to sham. C) There is a weak rise in Iba1 mRNA expression
in LP MIA animals. D) GFAP mRNA levels remain similar between MIA and sham groups. E) There is a signiﬁcant increase in IL-1bmRNA expression in LP MIA animals. F) IL-6 mRNA
levels remain similar between MIA and sham groups. G) TNFamRNA levels remain similar between MIA and sham groups (AeB: for mRNA expression normalized to sham controls
a KruskalleWallis test was used, CeG: for mRNA expression expressed as 2-DCT values an independent samples t-test was used. *P < 0.05).
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YJOCA4378_proof ■ 9 January 2019 ■ 9/11reporting that ATF-3 upregulation only occurred later in the
model.25,41,42 Furthermore, no study reported an increase in ATF-3
positive neurons in the L3 DRGs, indicating the reported neuro-
pathic component was not a result of damage to peripheral affer-
ents innervating the subchondral bone.25,40e42 Furthermore,
Thakur et al. reported that 20% of L5 DRG cells bodies showed
positive staining for ATF-3, whereas the neuronal tracer experi-
ment in this study indicated that only 4e6% of L4 and L5 neurons
innervated the knee.25 In addition, ATF-3 staining in the ventral
horn indicated damage to motor neurons surrounding the knee,
suggesting leakage of MIA from the intraarticular space, yet we
identiﬁed no ATF-3 positive staining in the ventral horn (data not
shown).25 These differences cannot be attributed to MIA dose or
volume injected, but could be down to precision with the injection
technique. In agreement with our ﬁndings, a mouse study found
few ATF-3 positive cell bodies in L3-L5 DRGs 7 days after MIA in-
jection, as only 2.1% of cell bodies displayed positive staining and
the authors concluded there was no evidence to suggest MIAPlease cite this article as: Lockwood SM et al., Characterisation of perip
Osteoarthritis, Osteoarthritis and Cartilage, https://doi.org/10.1016/j.joca.induced sensory neuron damage.9 Overall, the lack of ATF-3
expression in this study suggests there is no MIA induced
neuronal damage and that an alternative mechanism must be
driving central changes in LP animals.
Glial cells, a major component of the central nervous system,
can respond to peripheral tissue damage, releasing factors that
interact with neurons to regulate their function.43,44 Previous
studies reported an increase in microglia proliferation and activa-
tion of in SC following MIA injection9,25,30. Importantly, increase in
the number of microglial cells was reported to be increased no
earlier than 28 days after MIA injection9. Indeed, in our study we
found no changes in Iba1 mRNA levels in the SC 14d after MIA in-
jection, suggesting no increase in the number of microglia cells up
to this time in this model. Beyond proliferation, when activated,
microglia can modulate the function of spinal neurons by releasing
pro-inﬂammatory cytokines34,45. Here, we show a signiﬁcant in-
crease in IL-1b mRNA expression in the SC dorsal horn 14d after
MIA injection. Notably, it has been suggested that IL-1b can130
heral and central components of the rat monoiodoacetate model of
2018.12.017
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YJOCA4378_proof ■ 9 January 2019 ■ 10/11inﬂuence synaptic transmission by enhancing AMPA and NMDA as
well as suppressing GABA and glycine induced currents in the SC
dorsal horn.46 It is believed therefore that microgliosis and the
subsequent release of IL-1b may be contributing the development
of central sensitisation,46 a feature we speculate to be occurring in
the model used in our study. Further, we report no increase in the
mRNA expression levels of the astrocytic marker GFAP in the MIA
animals, which is in agreement with previous ﬁndings where an
increase in GFAP expression can only be observed at later time
points of 28d post MIA injection.30 Investigating the molecular and
cellular changes in the microglia at the single cell and population
levels48,49 after MIA injection, which are beyond the scope of this
study, would be necessary to further characterize microglia pro-
liferation and activation and potentially target the microgliosis
observed in this model.
Many OA patients develop referred pain, and a subset are left
with persistent pain following total joint replacement surgery,
indicating OA associated chronic pain cannot always be explained
by purely peripheral mechanisms.50 An alteration in descending
controls, together with central sensitisation may be responsible for
this persistent pain. Indeed, clinical studies in OA patients have
shown a loss of CPM and an abnormal descending system from the
PAG to the SC.21,50 This study agrees with pre-existing evidence that
an imbalance in inhibitory and facilitatory descending controls
develops as the MIA model progresses.24,37 Overall, the develop-
ment of chronic pain as a result of OA may be attributed to both
peripheral mechanisms due to joint damage, and subsequent cen-
trally mediated mechanisms. Both mechanisms should be consid-
ered when deciding on the appropriate analgesics for patients.95
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